PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING
May 1, 2020, 00:00
10.1016/j.jval.2020.04.220
https://www.valueinhealthjournal.com/article/S1098-3015(20)30408-3/fulltext
Title :
PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30408-3&doi=10.1016/j.jval.2020.04.220
First page :
Section Title :
Open access? :
No
Section Order :
10080